Transplant Diagnostics Market 2017-2023
- November, 2017
- Domain: Healthcare - Diagnostics
- Get Free 10% Customization in this Report
The transplantation diagnostics market is booming due to the growing patient base for chronic disease globally, growing elderly population, and the increasing number of organ transplantation procedures. High cost of sequencing instrument, requirement of skilled labors, and the difference between organs donated and patients waiting for transplantation are some of the factors hampering the market growth. The market in emerging countries is expected to grow at a rapid pace during the forecast period due the increasing healthcare awareness among public, growing patient pool, and the increasing healthcare spending.
The “Global Transplantation Diagnostics Market” is estimated to witness a CAGR of 10.9% during the forecast period 2017–2023. The market is analyzed based on six segments, namely technology, products, screening methods, application, end-users, and regions.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the transplantation diagnostics market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions.
The global transplantation diagnostics market by technology is segmented into molecular assays and non-molecular assays. Molecular assays include PCR-based and sequencing-based assays. Molecular assays occupy the largest share in 2016 due to its better sensitivity, specificity, and high resolving power.
The global transplantation diagnostics market by product type is segmented into instruments, consumables & reagents, and softwares and services. Reagents and consumables occupy the major market share in 2016 due to repeat purchase of the consumables and reagents to perform the tests.
Screening Method Analysis
The global transplantation diagnostics market by screening method is segmented into pre-transplantation screening and post-transplantation screening. Post-transplantation screening occupies the major market share in 2016.
The global transplantation diagnostics market by application is segmented into diagnostic and research applications. Diagnostic application occupies the largest market share and is expected to be the fastest growing segment during the forecast period.
The global transplantation diagnostics market by end-users is segmented into hospital & transplant centers, commercial service providers, and academics and research laboratories. Hospital and transplant centers occupy a major share of transplantation diagnostics market in 2016 due to an increase in surgical procedures.
Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Immucor, Inc., CareDx, Inc., Abbott Laboratories, Qiagen N.V., bioMerieux S.A., F. Hoffmann-La Roche, Omixon Ltd, and other predominate & niche players.
Currently, the diagnostic assays based on molecular method dominates the global transplantation diagnostics market. A lot of new players are concentrating on this market to provide innovative tests to detect acute rejection within few weeks of transplantation with high sensitivity and specificity. The key market players are acquiring small companies to enhance their product portfolio and strengthen their leadership position in the market. Apart from this, major players are launching innovative tests to have an edge in the market. For instance, in February 2017, Immucor Inc. launched MIA FORA NGS FLEX HLA Typing Assay that provides comprehensive coverage of up to 11 HLA genes. The company also launched molecular gene expression assay, kidney Solid Organ Response Test (kSORT), to predict organ rejection and graft injury in May 2016.
The report provides complete details about the usage and adoption rate of transplantation diagnostics products in various applications and regions. With that, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward test adoption in the upcoming years along with the details of commercial tests available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Importance of Transplantation Diagnostics
3.3 Limitations of Transplantation Diagnostics
3.4 Segmented Addressable Market
3.5 Trends in the Transplantation Diagnostics Market
3.6 Related Markets
3.6.1 Liquid Biopsy
3.6.2 Cell-free DNA Testing
3.6.3 Point-of-Care Diagnostics
4 Market Outlook
4.2 Recent Product Launches
4.3 Market Segmentation
4.4 PEST Analysis
4.5 Porter 5 (Five) Forces
5 Market Characteristics
5.1 DRO Analysis
18.104.22.168 Growing patient base suffering from chronic diseases
22.214.171.124 Increasing number of organ transplantation procedures
126.96.36.199 Growing elderly population
188.8.131.52 New test development and launch
184.108.40.206 Increasing adoption of modern techniques for HLA typing
220.127.116.11 High cost of sequencing instrument and requirement of skilled labors
18.104.22.168 Difference between organs donated and patients waiting for transplantation
6 Technology: Market Size and Analysis
6.2 Molecular Assays
6.2.1 PCR-based Molecular Assays
6.2.2 Sequencing-based Molecular Assays
6.3 Non-molecular Assays
7 Products: Market Size and Analysis
7.3 Consumables & Reagents
7.4 Software & Services
8 Screening Methods: Market Size and Analysis
8.2 Pre-transplantation Screening
8.3 Post-transplantation Screening
9 Application: Market Size and Analysis
9.2 Diagnostic Applications
9.3 Research Applications
10 End-users: Market Size and Analysis
10.2 Hospital & Transplantation Centers
10.3 Academic Institutions & Research Laboratories
10.4 Commercial Service Providers
11 Regions: Market Size and Analysis
11.2 North America
11.4 Asia Pacific
11.5 Rest of the World
11.5.3 Middle East
12 Competitive Landscape
13 Vendor Profiles
13.1 Thermo Fisher Scientific Inc.
13.1.2 Geographic Revenue
13.1.3 Business Focus
13.1.4 SWOT Analysis
13.1.5 Business Strategies
13.2 Illumina Inc.
13.2.2 Geographic Revenue
13.2.3 Business Focus
13.2.4 SWOT Analysis
13.2.5 Business Strategies
13.3 Bio-Rad Laboratories
13.3.2 Business Units
13.3.3 Geographic Revenue
13.3.4 Business Focus
13.3.5 SWOT Analysis
13.3.6 Business Strategies
13.4 Immucor Inc.
13.4.2 Business Units
13.4.3 Geographic Revenue
13.4.4 Business Focus
13.4.5 SWOT Analysis
13.4.6 Business Strategies
13.5 CareDx, Inc.
13.5.2 Business Units
13.5.3 Geographic Revenue
13.5.4 Business Focus
13.5.5 SWOT Analysis
13.5.6 Business Strategies
14 Companies to Watch for
14.1 Abbott Laboratories (Abbott)
14.2 Qiagen N.V.
14.3 bioMerieux S.A.
14.4 F. Hoffmann-La Roche
14.5 Omixon Ltd.
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.